Daily Report — September 28, 2026
Morning Brief — Monday, September 28, 2026
Market Overview
Equity futures are under modest pressure this morning as oil prices spike on renewed Middle East tensions (U.S.-Iran Strait of Hormuz standoff), with SPY futures down ~0.3% pre-bell. The macro backdrop remains hostile: 30-year Treasury yields are at 20-year highs, University of Michigan consumer sentiment sits at 48.1 (near historic lows), and households are pricing in 4.6% inflation — a combination that keeps rate-cut hopes on ice. The week ahead is data-heavy (September jobs report, Micron earnings reaction) and headline-driven, meaning intraday volatility will be the dominant theme.
Claude’s Call
FLAT-to-DOWN — The oil spike is the deciding factor today; energy-driven inflation fears compress growth multiples and the macro headwinds (5%+ long yields, weak sentiment) give bulls nothing new to work with. The broad index likely churns in a tight range with a downside bias, though the AI/semiconductor names catching bids (CRDO, TSEM, BE) could mask index weakness in the Nasdaq.
Top Movers
KOD (+112.9%) — $68.87 → $80.85 (+17.4% upside) Thesis: This is the real deal — a Phase 3 DAYBREAK trial win in wet AMD (age-related macular degeneration) is a binary catalyst, not a rumor-driven pop. Kodiak’s Zenkuda drug is headed for regulatory filing, positioning it as a direct rival to Regeneron’s $5B+ Eylea franchise. The stock ran from ~$32 to nearly $70 on 6x average volume, which is massive conviction. Technically, it’s now AT the 6-month high ($69.89), so the immediate breakout level is confirmed — the next fib extension target is $80.85 (1.272). That said, +112% in a single session means most of the easy money is made. The stock’s RSI is a neutral 50 (pre-move baseline), but post-move you’re likely looking at an overbought reading. This is NOT a chase — it’s a hold-if-you-own, and for new entries, wait for the first pullback. Levels: Exit/take partial at $80.85 (fib 1.272 extension). Support/re-entry at $60.38 (fib 23.6%) or $54.50 (fib 38.2%) on any post-catalyst pullback.
CRDO (+7.65%) — $210.97 → $251.85 (+19.3% upside) Thesis: Credo Technology is one of the cleanest AI infrastructure plays in the mid-cap space — its 1.6T optical transceiver expansion directly addresses hyperscaler demand, and revenue grew 114.7% YoY. This week’s move is part of a broader AI networking re-rating, supported by the new ZeroFlap 224G optical lineup announcement. Technically, CRDO is sitting just above the $195.16 fib 50% support and below the $220.50 fib 38.2% resistance — it’s in the middle of its range from the 6-month swing, which actually makes this a reasonable entry, not a chase. The SMA-50 is $210, right where the stock is trading — that’s a critical test. A close above $220 would be a clean technical breakout. Levels: Exit at $251.85 (fib 38.2% from 6mo swing, prior resistance zone). Stop/support at $195.16 (fib 50%) — a break below that gets ugly toward $169.
BE (+8.27%) — $288.70 → $292.43 (+1.3% near-term) / $345.85 prior high Thesis: Bloom Energy is the cleaner AI power play that institutional money is rotating into — data center power demand is secular, and BE broke out of a technical base on Friday. The Zacks Focus List inclusion adds a modest institutional tailwind. However, at $288.70, the stock is approaching the fib 23.6% resistance at $292.43 from the 6-month swing — that’s the first real wall. The SMA-50 at $230 is well below, meaning the stock has already made a big move off the lows ($119.51 six months ago). BE is extended on a 6-month basis but the AI power theme has genuine duration. Don’t chase the opening gap — look for a pullback toward $259 (fib 38.2%) as a better entry. Levels: Near-term resistance at $292.43 (fib 23.6%). Stronger resistance at prior 6mo high $345.85. Support at $259.39 (fib 38.2%) — that’s your stop reference.
MXL (+10.0%) — $93.84 → $101.61 (+8.3% upside) Thesis: MaxLinear’s AI optical story is finally getting traction — the Keystone ramp and 800G/1.6T pipeline are real catalysts for 2027-28 revenue visibility, and 55.2% revenue growth justifies the re-rating. The stock has moved from a 6-month low of $16.08 to $93.84, which is extraordinary recovery. Technically, it just broke above the SMA-50 ($71.86) convincingly and is approaching the fib 23.6% support/resistance at $101.61 from the 6-month swing. The valuation is flagged EXPENSIVE at 35x forward P/E vs. 18.6x peer median — BUT the PEG on 55% growth makes that more palatable (PEG ~0.64, which is actually cheap). This has more room if AI optical demand accelerates. Levels: First exit at $101.61 (fib 23.6%). Longer-term target toward prior high at $128.03. Support at $85.27 (fib 38.2%) — don’t hold below that level.
VIAV (+9.27%) — $40.68 → $43.57 (+7.1% upside) Thesis: Viavi Solutions has been a quiet 196% 12-month winner on the AI data center testing and 6G wireless theme, with the Spirent acquisition adding diversification. Today’s move is partly rate-relief sympathy (yields eased Friday, stocks caught a bid) and partly the AI data center buildout theme continuing to bid up networking test infrastructure names. RSI at 59.9 means not yet overbought — there’s room before it gets extended. Technically, the stock is AT the 6-month 20-day high ($40.68), which is a new near-term breakout. The SMA-50 ($38.11) is well below as support. This is a real AI infrastructure pick, not sector sympathy noise. Levels: Exit at $43.57 (fib 50% from 6mo swing). Next level $46.35 (fib 38.2%). Stop at SMA-50 $38.11 — a clean level to define your risk.
AMPX (+10.32%) — $10.76 → $13.97 (+29.8% upside) Thesis: A $75M Department of War grant to retrofit a domestic battery production line is a real, hard-dollar catalyst — not vague AI hype. For a company with a $34M quarterly revenue run rate (126% YoY growth) and raised guidance, this grant is transformational for manufacturing scale. The drone battery demand angle is credible given the defense spending environment. Technically, the stock is recovering from a 6-month low of $8.44 and just cleared the SMA-50 ($10.22) — that’s a legitimate technical confirmation. However, the stock is well below its 6-month high ($22.91), so the fib retracement levels above ($13.97 fib 61.8%) remain meaningful resistance. Levels: First exit at $13.97 (fib 61.8%). Next resistance at $15.67 (fib 50%). Stop at SMA-50 $10.22 — break below invalidates the setup.
TSEM (+6.07%) — $230.47 → $237.72 (+3.1% near-term) / $279.50 medium-term Thesis: Tower Semiconductor earned its move — PHLX Semiconductor Index inclusion (forced index buying), Mizuho initiated with Outperform and $300 price target, and a $4B Japan capacity expansion plan that takes production to 45,000 300mm wafer equivalents/month by 2029. The AI optical foundry angle is the real growth driver here. Technically, the stock sits just below the fib 50% resistance at $237.72 from the 6-month swing — a clean break above that opens $256-$279. The SMA-50 ($225.20) is right at current price levels, making this a pivotal technical moment. Levels: Near-term exit at $237.72 (fib 50%). Medium-term target $256.39 (fib 38.2%). Stop at $219.04 (fib 61.8% support) — below there and the Mizuho thesis gets questioned.
QMCO (+7.43%) — $31.68 → $39.12 (+23.5% upside) Thesis: Quantum Corp just got added to the S&P Technology Hardware Select Industry Index — that’s forced index buying and a real structural catalyst. The 127.75% 12-month return is backed by genuine fundamentals: AI-driven tape storage demand, expanding margins, and a debt-free balance sheet post-turnaround. RSI at 77.5 is the warning flag here — this is overbought territory, and the stock is AT the 6-month high ($31.68). The S&P index inclusion pop is real but often fades after settlement. The fib 1.272 extension at $39.12 is achievable on a continued index flow bid, but chasing at 77 RSI is risky. Levels: Target $39.12 (fib 1.272 extension) if index flow continues. Support at $25.22 (fib 23.6%) — that’s a long way down if sentiment turns. Proceed with caution.
Headlines to Watch
-
“Nasdaq, S&P 500 Futures Fall As Oil Spikes On Trump’s Snub To Iran” — Oil spike is the macro risk today; energy cost inflation pressures consumer and tech margin expectations simultaneously — watch XLE vs. QQQ divergence as a risk barometer.
-
“Kodiak Sciences Stock Soars on Positive AMD Trial Data” — The wet AMD space just got a new competitor to Regeneron’s Eylea; watch REGN for sympathy weakness and KOD for post-catalyst profit-taking into the close.
-
“Amprius Technologies Stock Jumps on $75M Defense Grant” — Defense battery manufacturing onshoring is a real theme; the grant provides non-dilutive capital at a critical scale-up moment — watch for follow-on contract announcements.
-
“Tower Semiconductor Plans $4BN Japan Chip Hub” — This is a multi-year capacity story; Mizuho’s $300 price target gives a 30%+ upside from current levels, and the PHLX inclusion forces passive buying — this move has institutional legs.
-
“Should VIAV Be in Your Portfolio After a 196.4% Gain in a Year?” — The question is whether Viavi’s testing infrastructure exposure to AI data centers and 6G is still early innings or fully priced; the Spirent acquisition integration is the key execution risk to monitor.
-
“Bloom Energy, TSM Lead 5 Stocks Near Buy Points As AI Rebounds” — AI power demand is not slowing; Bloom Energy’s fuel cell infrastructure play and Taiwan Semi’s foundry dominance are two different ways to play the same megatrend — both near technical buy points.
-
“Why Stocks Can Rally Despite 20-Year-High Bond Yields? ETFs in Focus” — The key question for today and the week: if bond yields are at 20-year highs and equities are holding up, either earnings are doing the heavy lifting or we’re setting up for a repricing event — the jobs report Friday will be decisive.
Claude’s Top Picks
CRDO (+7.65% today, +19.94% week) — $210.97 → $251.85 (+19.3% upside) Valuation: FAIR at 21x forward P/E vs. 18.6x peer median — but with 114.7% revenue growth, this is genuinely cheap on a PEG basis (PEG ~0.18). Upside: The 1.6T optical transceiver ramp directly serves the hyperscaler AI buildout, and the new ZeroFlap 224G lineup extends the product cycle well into 2027-28. Risk: Customer concentration is severe — 10 customers account for 90% of sales; any single hyperscaler pause in capex destroys the thesis immediately. Stop reference: $195.16 (fib 50% support)
VIAV (+9.27% today, +15.05% week) — $40.68 → $46.35 (+13.9% upside) Valuation: No comps data provided, but at $40/share with a 196% 12-month run on genuine AI testing demand, this is not a frothy valuation for the theme. Upside: RSI at 59.9 means NOT overbought yet — rare for a stock up 9% on the day — and the 6G/data center testing theme has multi-year duration with Spirent as a growth accelerant. Risk: Soft wireless demand is a real headwind flagged by management; if telecom capex continues to lag, the NSE segment carries the whole company. Stop reference: SMA-50 at $38.11
AMPX (+10.32% today, +11.93% week) — $10.76 → $13.97 (+29.8% upside) Valuation: Pre-profit growth stage; EV/Revenue is the relevant metric — with 126% YoY growth and a DoW grant de-risking the manufacturing scale-up, the risk/reward is asymmetric. Upside: The $75M non-dilutive DoW grant removes the biggest near-term risk (capital for manufacturing) and validates the defense drone battery thesis in a single announcement. Risk: Single-product risk remains (high-energy density silicon anode cells) and the DoW is the dominant customer — concentration risk is extreme if defense budgets shift. Stop reference: SMA-50 at $10.22
TSEM (+6.07% today, +3.07% week) — $230.47 → $256.39 (+11.3% upside) Valuation: No comps data but Mizuho’s $300 target implies ~30% upside from current; specialty foundry with AI optical exposure trades at a discount to pure-play AI names. Upside: PHLX index inclusion creates mechanical buying pressure from passive funds, and the $4B Japan expansion plan gives institutional investors a long-duration capex story to underwrite. Risk: The 90-day return was -9.83% before this week’s recovery — the stock has been under distribution, and a broader chip sector sell-off on yield concerns would hit this name hard. Stop reference: Fib 61.8% support at $219.04
MXL (+10.0% today, +15.68% week) — $93.84 → $101.61 (+8.3% near-term) / $128.03 (+36.4% full recovery) Valuation: EXPENSIVE at 35x forward P/E vs. 18.6x peer median — BUT PEG of ~0.64 on 55.2% growth makes this a value play by growth-adjusted metrics, not a stretched one. Upside: The AI optical infrastructure story (800G, 1.6T) is just beginning its ramp and MXL’s Keystone product is positioned directly in the hyperscaler upgrade cycle through 2028. Risk: The EV/EBITDA is deeply negative (-383x) suggesting the company is burning cash — if the ramp takes longer than expected, this valuation requires perfection on execution. Stop reference: SMA-50 at $71.86 (well below — use $85.27 fib 38.2% as a tighter stop)
Avoid
KOD — Up 112.9% on genuine Phase 3 trial news, but at the 6-month high with the easy money already made; new buyers at $69 are buying someone else’s lottery ticket — wait for the post-catalyst consolidation around $54-$60 (fib 38.2%-23.6%) before considering entry.
QMCO — RSI at 77.5 is a hard no for new longs; the S&P index inclusion pop is real but historically fades within 5-10 trading days after the rebalance date, and the stock is AT a 6-month high with zero technical support nearby until $25.22 (a 20% drop).
BE — Bloom Energy is a legitimate AI power play but up 8.3% today and already 141% off its 6-month low ($119 → $288); approaching the fib 23.6% resistance at $292.43 with the prior high at $345 as the real target — this is a hold-what-you-own, not a buy-the-open situation. Let it digest before adding exposure.
WSB Sentiment Check
MU — WSB says: BULLISH (80% bullish, 116 mentions, 388 upvotes) Claude says: PARTIALLY AGREE — Micron reported yesterday (EPS $44.27) with essentially zero reaction (+0.09%), which is actually a yellow flag; the stock needs an upside guide revision to re-rate from $1,065, and the analyst target of $1,520 implies 43% upside — but “reported with no reaction” means the beat was already priced in. Technically, $1,065 is between fib 23.6% support ($1,002) and the 6-month high ($1,213) — it’s in no-man’s land. Wait for the earnings call reaction to fully digest before loading.
NVDA — WSB says: BULLISH (80% bullish, 67 mentions, 440 upvotes) Claude says: AGREE — NVDA at $232 is approaching its 6-month high ($235.20) with SMA-50 at $216 as solid support; the stock is in a confirmed uptrend and the AI demand narrative has not shown any cracks. The fib 1.272 extension at $254.35 is the next real target. This is one of the few large-cap names where WSB and fundamentals are aligned. Not a short-term trade — it’s a core position with a defined stop at $216.
META — WSB says: BULLISH (80% bullish, 53 mentions, 242 upvotes) Claude says: PARTIALLY AGREE — META at $726 is just above the fib 23.6% support at $720.45 from the 6-month swing, which is actually a fragile technical position; a close below $720 turns this into a potential breakdown toward $685. The Muse AI agent rollout is a real engagement catalyst, but the stock is 36% off its 6-month low ($535) — a lot of good news is already reflected. SMA-50 at $617 shows how extended this has become. Trim into strength, don’t add.
AMD — WSB says: BULLISH (80% bullish, 42 mentions, 291 upvotes) Claude says: AGREE with caution — AMD at $623 is within 1.2% of its 6-month high ($630.63) on a massive 6-month recovery from $196 — that’s a 218% move. The AI GPU competition narrative is real and AMD’s MI300X ramp gives them credibility. BUT the fib 23.6% support is all the way down at $528 — there’s very little technical cushion if sentiment turns. The risk/reward for new longs here is poor. WSB is right on the thesis, wrong on the timing.
MSFT — WSB says: BULLISH (80% bullish, 29 mentions, 44 upvotes) Claude says: AGREE — The lowest-conviction WSB pick by engagement (44 upvotes vs. 440 for NVDA) but actually the best risk/reward: MSFT at $505.75 with SMA-50 at $477.66 as a well-defined stop, Akamai’s $11.6B Anthropic cloud deal showing enterprise AI spend is accelerating, and Azure cloud growth as the steady compounder. The Copilot monetization cycle is still early. This is the boring-but-right trade. Technically within 2% of its 6-month high — that’s healthy consolidation, not exhaustion.
Earnings Scorecard
| AYI (Acuity Inc.) — REPORTED | EPS: $15.04 | Stock: -3.57% | Reaction: Unjustified over-reaction — Analyst target at $398 vs. current implied price suggests the market punished a lighting/controls company that actually delivered solid EPS; this looks like a buy-the-dip if the guide held. |
| ADYEY (Adyen N.V.) — REPORTED | EPS: $0.40 | Stock: +3.21% | Reaction: Justified and measured — Adyen’s Guidewire partnership deal is a real revenue diversification event; +3.2% on a European fintech processor is a healthy non-euphoric reaction. Still constructive. |
| FDS (FactSet Research) — REPORTED | EPS: $15.18 | Stock: -2.33% | Reaction: Likely justified — FactSet is a mature data/analytics business trading at a premium ($270 analyst target); without an upside guide revision, flat-to-down reactions are normal. Not a buy-the-dip here. |
| JBL (Jabil Inc.) — REPORTED | EPS: $7.98 | Stock: +1.23% | Reaction: Slightly under-reacted — Jabil’s AI server manufacturing exposure is underappreciated at a $430 analyst target; +1.2% on what appears to be a solid print is muted. This could be a quiet buy-the-dip in the contract manufacturing space. |
| CAG (ConAgra Brands) — REPORTED | EPS: -$4.00 | Stock: -1.19% | Reaction: Reaction is TOO MILD — a -$4.00 EPS print (vs. expected decline) on a consumer staples name with an analyst target of only $14.41 is deeply troubled; -1.2% understates the fundamental damage. Avoid and potentially short on bounces. |
| NKE (Nike Inc.) — REPORTED | EPS: $2.10 | Stock: -0.49% | Reaction: Essentially flat — Piper Sandler cut their price target pre-earnings and the consensus was already bearish; $2.10 EPS apparently met the lowered bar. The analyst target at $46.32 suggests meaningful downside from current levels. Not a buy-the-dip — the Nike turnaround thesis needs more proof points. |
| KMX (CarMax) — REPORTED | EPS: $1.61 | Stock: +0.31% | Reaction: Fair — used car market is normalizing; $57 analyst target vs. current price is nearly in-line. No edge here. |
| CCL (Carnival Corp.) — REPORTED | EPS: $2.22 | Stock: -0.31% | Reaction: Justified — “Record quarter meets fuel bill nobody can hedge away” is the perfect summary; the oil spike today is an incremental negative for CCL as Q4 fuel costs rise. The -0.31% understates the forward headwind from today’s oil move. Pass. |
| MU (Micron Technology) — REPORTED | EPS: $44.27 | Stock: +0.09% | Reaction: Significantly under-reacted OR fully priced — With an analyst target of $1,520 (43% above current $1,065), either the market doesn’t believe the guide or the print was exactly in line. The near-zero reaction on heavy WSB interest (116 mentions, 80% bullish) suggests bulls are frustrated. This sets up as a potential slow drift higher if AI memory pricing holds — but don’t chase the open. |
| MKC (McCormick) — REPORTED | EPS: $6.01 | Stock: +0.06% | Reaction: Fully priced — Analyst target at $60 (likely already trading near there); UBS said they’d maintain guidance and they did. Nothing to act on here. |
This brief is for informational purposes only and does not constitute investment advice. All technical levels and price targets are based on publicly available data as of September 28, 2026.